Literature DB >> 19608932

Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?

Ainara Cano1, Fiorella Ciaffoni, Ghada M Safwat, Patricia Aspichueta, Begoña Ochoa, Elena Bravo, Kathleen M Botham.   

Abstract

The overproduction of very-low-density lipoprotein (VLDL) is a characteristic feature of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to use a high-fat diet-induced model of NAFLD in rats to investigate 1) the influence of the disease on hepatic VLDL processing in the endoplasmic reticulum and 2) the potential modulatory effects of dietary coenzyme Q (CoQ). Rats were fed a standard low-fat diet (control) or a diet containing 35% fat (57% metabolizable energy). After 10 wk, high-fat diet-fed animals were divided into three groups: the first group was given CoQ9 (30 mg*kg body wt(-1)*day(-1) in 0.3 ml olive oil), the second group was given olive oil (0.3 ml/day) only, and the third group received no supplements. Feeding (3 high-fat diets and the control diet) was then continued for 8 wk. In all high-fat diet-fed groups, the content of triacylglycerol (TG) and cholesterol in plasma VLDL, the liver, and liver microsomes was increased, hepatic levels of apolipoprotein B48 were raised, and the activities of microsomal TG transfer protein and acyl CoA:cholesterol acyltransferase were reduced. These findings provide new evidence indicating that VLDL assembly and the inherent TG transfer to the endoplasmic reticulum are altered in NAFLD and suggest a possible explanation for both the overproduction of VLDL associated with the condition and the disease etiology itself. Dietary CoQ caused significant increases in apolipoprotein B mRNA and microsomal TG levels and altered the phospholipid content of microsomal membranes. These changes, however, may not be beneficial as they may lead to the secretion of larger, more atherogenic VLDL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608932     DOI: 10.1152/japplphysiol.00297.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.

Authors:  Ainara Cano; Xabier Buqué; Maite Martínez-Uña; Igor Aurrekoetxea; Ariane Menor; Juan L García-Rodríguez; Shelly C Lu; M Luz Martínez-Chantar; José M Mato; Begoña Ochoa; Patricia Aspichueta
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

Review 2.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

3.  PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.

Authors:  E Matthew Morris; Grace M E Meers; Frank W Booth; Kevin L Fritsche; Christopher D Hardin; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-16       Impact factor: 4.052

4.  A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease.

Authors:  Emma De Feo; Consuelo Cefalo; Dario Arzani; Rosarita Amore; Raffaele Landolfi; Antonio Grieco; Walter Ricciardi; Luca Miele; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2012-02-15       Impact factor: 2.316

5.  High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway.

Authors:  Elena Bravo; Simonetta Palleschi; Patricia Aspichueta; Xabier Buqué; Barbara Rossi; Ainara Cano; Mariarosaria Napolitano; Begoña Ochoa; Kathleen M Botham
Journal:  Lipids Health Dis       Date:  2011-04-19       Impact factor: 3.876

6.  LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL.

Authors:  Makoto Kurano; Naoyuki Iso-O; Masumi Hara; Nobukazu Ishizaka; Kyoji Moriya; Kazuhiko Koike; Kazuhisa Tsukamoto
Journal:  Lipids Health Dis       Date:  2011-08-05       Impact factor: 3.876

7.  The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats.

Authors:  Madiha Dhibi; Faten Brahmi; Amira Mnari; Zohra Houas; Issam Chargui; Linda Bchir; Noureddine Gazzah; Mohammed A Alsaif; Mohamed Hammami
Journal:  Nutr Metab (Lond)       Date:  2011-09-23       Impact factor: 4.169

8.  Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in rats.

Authors:  Elena Bravo; Simonetta Palleschi; Barbara Rossi; Mariarosaria Napolitano; Luca Tiano; Emanuela D'Amore; Kathleen M Botham
Journal:  Int J Mol Sci       Date:  2012-02-02       Impact factor: 6.208

Review 9.  Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.

Authors:  Rohit A Sinha; Eveline Bruinstroop; Brijesh K Singh; Paul M Yen
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

Review 10.  The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression.

Authors:  Kathleen M Botham; Mariarosaria Napolitano; Elena Bravo
Journal:  Nutrients       Date:  2015-12-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.